The trademark TYLENOL was filed by Kenvue Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 26, 2023, and received one opposition filed on November 13, 2023 by Nobel Pharma EOOD on Likelihood of confusion. the opponent was represented by BUREAU IGNATOV & SON and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 13, 2023
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).